Status:
COMPLETED
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Long-term Effects Secondary to Cancer Therapy in Children
Lymphoma
Eligibility:
All Genders
Brief Summary
RATIONALE: Assessing the long-term effects of cancer treatment in cancer survivors may help improve the ability to plan effective treatment and follow-up care. PURPOSE: This clinical trial is studyin...
Detailed Description
OBJECTIVES: * Determine the cumulative incidence and characterize the spectrum of selected adverse physiologic and psychosocial outcomes, using self-report and clinical evaluation, in patients previo...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Contemporary cohort
- At least 5 years since diagnosis of Hodgkin's lymphoma
- Diagnosed between the years 1987-2001
- 21 and under at diagnosis
- No evidence of disease
- Prior treatment on 1 of the following protocols during the years 1987-2001:
- Children's Cancer Group (CCG) CCG-5942, CCG-59704
- Pediatric Oncology Group (POG) POG-8625, POG-8725, POG-9425, POG-9426
- Pediatric Hodgkin's Consortium: VAMP, VEPA, VAMP/COP
- Institutional protocols COPP/ABV, MOPP/ABVD, ABVD
- Childhood Cancer Survivor Study (CCSS) Hodgkin's lymphoma cohort
- Current enrollment in the CCSS
- Diagnosed between the years 1976-1986
- Completed baseline questionnaire at comparable timepoints (as the contemporary cohort) after diagnosis
- PATIENT CHARACTERISTICS:
- Age
- Any age
- Performance status
- Not specified
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- PRIOR CONCURRENT THERAPY:
- Biologic therapy
- Not specified
- Chemotherapy
- Not specified
- Endocrine therapy
- Not specified
- Radiotherapy
- Not specified
- Surgery
- Not specified
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
530 Patients enrolled
Trial Details
Trial ID
NCT00091091
Start Date
December 1 2004
Last Update
July 16 2018
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Lucile Packard Children's Hospital at Stanford University Medical Center
Palo Alto, California, United States, 95798
2
Yale Cancer Center
New Haven, Connecticut, United States, 06520-8028
3
University of Chicago Cancer Research Center
Chicago, Illinois, United States, 60637-1470
4
Hackensack University Medical Center Cancer Center
Hackensack, New Jersey, United States, 07601